Table 1 Patients’ characteristics
n = 40 | ||
|---|---|---|
Age (range) | 64.5 (34–73) | |
Gender | Male | 23 (57.5%) |
Female | 17 (42.5%) | |
Performance status | 0 | 34 (85.0%) |
1 | 6 (15.0%) | |
Smoking history | Yes | 23 (57.5%) |
Histology | Adenocarcinoma | 38 (95.0%) |
Pleomorphic carcinoma | 1 (2.5%) | |
Non-small cell lung cancer | 1 (2.5%) | |
Stage | IIIB | 1 (2.5%) |
IV | 30 (75.0%) | |
Postoperative recurrence | 9 (22.5%) | |
EGFR mutation | Positive | 23 (57.5%) |
Negative | 16 (40.0%) | |
Unknown | 1 (2.5%) | |
Previous adjuvant chemotherapy | Yes | 6 (15.0%) |
Previous EGFR-TKI therapy | Yes | 8 (20.0%) |